PBT up 53% but Infratil swung from $424m net cash to $2.7bn net debt

What changed

Continuing-operations performance stepped up materially. Revenue rose 11.7% to NZD 604.4m and profit before tax advanced 53.2% to NZD 297.9m, with net profit from continuing operations rising to NZD 220.8m from NZD 136.4m. Reported NPAT fell 67.6% to NZD 350.5m, but that is an artefact of comparability: the HY22 base included a NZD 993.9m after-tax gain from discontinued operations, versus NZD 336.5m in HY23. The mix has also rotated — Diagnostic Imaging Australasia is now the largest revenue segment at 49.4% of group revenue (HY23 NZD 298.5m vs HY22 NZD 190.1m), while the energy line has transitioned from legacy Trustpower to Manawa.

The balance sheet is where the release reads hardest. Cash fell to NZD 522.5m from NZD 1,213.8m, gross borrowings rose to NZD 3,260.6m from NZD 789.5m, and the group moved from a net cash position of NZD 424.3m to net debt of NZD 2,738.1m. Operating cash outflow widened to NZD 234.6m from NZD 17.4m, capex stepped up to NZD 51.9m, and the interim dividend was lifted 3.8% to 6.75 cents.

What matters

• The earnings read is much cleaner than the headline suggests. NPAT down 67.6% is dominated by the lapping of the Trustpower-era discontinued gain. PBT up 53.2% and continuing-ops NPAT up from NZD 136.4m to NZD 220.8m are the appropriate operating comparators, and both look solid.
• Leverage has taken a step change. Gross borrowings grew by roughly NZD 2.47bn in a single year, taking the group to ~NZD 2.74bn net debt. Total equity rose 18.3% and total assets 10.9%, so the balance sheet has been recapitalised towards debt rather than equity. This reshapes the earnings quality debate: going forward, finance costs and coverage ratios matter more than they did 12 months ago.
• Cash conversion deteriorated materially. Pre-lease free cash flow was negative NZD 286.5m versus negative NZD 55.1m, and FCF-to-NPAT on continuing-operations basis is firmly negative. The dividend increase is being funded from balance-sheet capacity, not in-period cash generation.

Expectations

No quantified forward-work target or earnings guidance was provided in the supplied materials, and Infratil does not disclose proportionate EBITDAF on a current-period reconciled basis in the excerpts supplied. Shape context is available but noisy: FY22 NPAT was heavily front-loaded because of the Trustpower disposal (HY22 was 92.4% of full-year NPAT), so the FY22 anchor is not a useful seasonal template for HY23. On the revenue line, HY23 annualises to roughly NZD 1,208.8m, around 40.8% above FY22's NZD 858.9m — consistent with the Diagnostic Imaging expansion and Manawa consolidation rather than underlying like-for-like growth at that pace. The release supports a constructive read on continuing-operations momentum; it does not support any firm view on full-year cash generation or leverage trajectory.

Quality of result

The PBT line looks durable: it is driven by higher continuing-operations contribution across Diagnostic Imaging (NZD 22.7m segment result versus a small loss), Wellington Airport (NZD 11.1m versus NZD 3.1m), and a sharply higher associates contribution (NZD 346.6m versus NZD 114.1m). The associates line is material and not revenue-backed, so a portion of group profit depends on equity-accounted results and potentially on valuation or revaluation movements within the Manawa Energy segment result, where the 136.3% result-to-revenue ratio flags non-operating items. The NZD 336.5m discontinued-operations contribution is explicitly non-recurring.

Cash quality is weaker than earnings quality. Operating cash outflow of NZD 234.6m against PBT of NZD 297.9m is a sharp divergence, and the effective tax rate fell to 25.9% from 29.9%, flattering NPAT by a few points. With capex running at 8.6% of revenue and rising, the combination of negative FCF, higher gearing, and a larger dividend base warrants attention.

Unresolved

• What drove the NZD 234.6m operating cash outflow in detail — working-capital build, interest timing, or one-off items — given that receivables, payables and OWC were not separately disclosed.
• How the NZD 2.47bn increase in gross borrowings maps to specific acquisitions or funding of Gurīn Energy, Diagnostic Imaging growth, and corporate activity, and what the resulting proportionate net debt / EBITDAF ratio is.
• The quantum and nature of non-operating items inside the Manawa Energy segment result (NZD 390.8m on NZD 287m of revenue) and how much of the associates contribution is cash-backed.
• Whether the lifted 6.75c interim dividend is being framed as covered by proportionate operating cash flow, given pre-lease FCF is negative.

This briefing cannot assess underlying portfolio valuation, proportionate EBITDAF, or covenant headroom, because the supplied materials do not quantify non-GAAP measures, NTA per share, or debt covenant metrics.

Key metrics

Segment breakdown

Analytical metrics

---

This analysis was generated using Annolyse, an AI-powered tool that analyses NZX/ASX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.